(31) identified five cases of BRCA gene reversal mutations in tumor DNA from 30 patients with high-grade serous ovarian cancer through NGS analysis of TP53, BRCA1, and BRCA2. Here, TP53 is linked to ovarian serous adenocarcinoma.